Pennant Group Sees Hospice Surge, Announces Acquisitions

Early action to stave off the fallout of the COVID-19 pandemic has paid off for The Pennant Group (NASDAQ: PNTG), which saw substantial growth in its hospice business during the first quarter, even as the company gears up for the forthcoming acquisition of three affiliated hospice providers located in the southwestern United States.  Post-acute providers […]

LHC Group Rebounds from COVID-19 Pitfalls, Hospice Growth Slowed

Though uncertainties abound through the rest of the year, hospice operations at LHC Group (NASDAQ: LHCG) are trending upwards despite a mid-March dip due to the fallout of the COVID-19 pandemic. As the crisis pits headwinds against many of the organization’s future projections, LHC Group remains optimistic, anticipating recovery stemming from federal funding relief, acquisitions […]

Amedisys Poised for COVID-19 Recovery, Further Hospice Growth

The Amedisys, Inc. (NASDAQ: AMED) hospice segment saw a drop in referrals and rising costs stemming from the COVID-19 pandemic during the first quarter of this year. Though the outbreak creates industry-wide uncertainty about the future, demographic tailwinds, de novo activity and acquisitions show promise for a strong recovery, including the company’s $235 million purchase […]

Brookdale Takes Hit From COVID-19, Hospice Service Keeps Growing

The ongoing pandemic and changing payment models for home health gut-punched Brookdale Senior Living (NYSE: BKD) in the first quarter of 2020, but the company continues to see strong volume growth in its hospice business.  Rising expenses and drops in occupancy and resident fee revenues in their senior housing segment took a financial toll on […]

Alacare Purchase Boosts Encompass Hospice Despite COVID-19 Woes

Encompass Health’s (NYSE: EHC) hospice business saw positive growth during the first quarter of 2020 despite the company suffering some blows due to the COVID-19 pandemic. The 2019 acquisition of Alacare Home Health & Hospice for $217 million continues to bear fruit, offering major contributions to the company’s hospice revenue during the first quarter, which […]

Rise in Days of Care Buoys VITAS During Pandemic

Like most health care providers, VITAS Healthcare is feeling the effects of the COVID-19 pandemic, but the company appears to be riding out the storm based on its first quarter results.  VITAS saw 10.1% increase in hospice revenues from prior year during Q1, with increased days of care as a prime contributor. VITAS is a […]

Pennant Group Anticipates Strong Hospice Growth in 2020

Hospice, home health and senior living provider the Pennant Group (NASDAQ: PNTG) saw significant growth in its hospice operations during 2019 and expects that trend to continue through 2020.  The company’s hospice admissions rose 30% during 2019, coupled with a 26% increase in average daily census. The company’s fourth quarter 2019 average daily hospice census […]

LHC Group Poised for 2020 Hospice Acquisitions

After an active 2019 in the mergers and acquisitions market Louisiana-based home health and hospice provider LHC Group (NASDAQ: LHCG) has fixed its eyes on further growth in 2020 and beyond. LHC Group engages in M&A primarily through joint ventures with hospitals and health systems, which has been the company’s most active growth front. Though […]

VITAS Focused on Hospice De Novo, Same-Store Growth Over Acquisitions in 2020

Record-high valuations in the hospice mergers and acquisitions market are leading VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHEM), to target growth through de novos and same-store admissions rather than purchasing smaller hospices.  Multiples in the home care and hospice space reached as high as 26x EBITDA during 2019, the most significant rise for […]

Acquisitions Continue to Drive Amedisys’ Hospice Growth

Acquisitions contributed significantly to the Amedisys (AMED) hospice segment growth during the fourth quarter of 2019, continuing a trend for the past several quarters.  The company was active in the hospice M&A space last year, completing several transactions that included its $340 million purchase of Compassionate Care Hospice in February and its tuck-in of RoseRock […]